Cost-Minimization Analysis Of Rivaroxaban In Comparison To Enoxaparin Plus Warfarin For The Treatment Of Venous Thromboembolism (Vte) Under The Private Healthcare System Perspective
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.888
https://www.valueinhealthjournal.com/article/S1098-3015(15)02964-2/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
325
First Page :
A394
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02964-2&doi=10.1016/j.jval.2015.09.888